Jean-Michel Molina Selected Research

Hepatitis C

1/2016	Estimated glomerular filtration rate but not solute carrier polymorphisms influences anemia in HIV-hepatitis C virus coinfected patients treated with boceprevir or telaprevir-based therapy.
4/2011	Correlates of poor perceived health among individuals living with HIV and HBV chronic infections: a longitudinal assessment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean-Michel Molina Research Topics

Disease

62	Infections 05/2024 - 04/2005
35	HIV Infections (HIV Infection) 03/2023 - 01/2003
15	Acquired Immunodeficiency Syndrome (AIDS) 03/2023 - 12/2003
14	Sexually Transmitted Diseases (Sexually Transmitted Disease) 03/2024 - 11/2005
11	Tuberculosis (Tuberculoses) 03/2024 - 07/2008
10	Viremia 01/2022 - 11/2005
9	Coinfection 01/2022 - 04/2011
7	Exanthema (Rash) 01/2021 - 11/2009
6	Hepatitis B 11/2023 - 11/2015
5	Headache (Headaches) 05/2024 - 04/2015
5	COVID-19 01/2024 - 12/2020
5	Dizziness (Lightheadedness) 01/2019 - 07/2011
5	Chronic Hepatitis C 01/2017 - 07/2010
5	Lipodystrophy 01/2011 - 03/2002
4	Immune Reconstitution Inflammatory Syndrome 03/2024 - 07/2008
4	Syphilis 11/2023 - 11/2018
4	Hepatitis 01/2023 - 04/2010
4	Microsporidiosis 01/2021 - 06/2002
4	Nausea 01/2020 - 08/2008
4	Fibrosis (Cirrhosis) 03/2016 - 02/2006
4	Liver Cirrhosis (Hepatic Cirrhosis) 12/2015 - 02/2006
3	Weight Gain 02/2024 - 01/2020
3	Pneumonia (Pneumonitis) 01/2024 - 01/2022
3	Inflammation (Inflammations) 03/2021 - 02/2020
3	Diarrhea 01/2006 - 06/2002
2	Gonorrhea 01/2023 - 11/2018
2	Hepatitis A (Hepatitis, Infectious) 01/2023 - 03/2012
2	Lymphoma (Lymphomas) 04/2022 - 12/2003
2	Disease Progression 01/2022 - 01/2021
2	Communicable Diseases (Infectious Diseases) 01/2022 - 01/2020
2	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 06/2005
2	Neoplasms (Cancer) 01/2019 - 06/2010
2	Hepatitis C 01/2016 - 04/2011
2	Anemia 01/2016 - 12/2014
2	Renal Insufficiency (Renal Failure) 08/2013 - 04/2003

Drug/Important Bio-Agent (IBA)

28	RNA (Ribonucleic Acid)IBA 12/2022 - 04/2005
22	Tenofovir (Viread)FDA Link 11/2023 - 04/2003
21	Emtricitabine (Emtriva)FDA Link 11/2023 - 04/2005
17	Raltegravir Potassium FDA Link 10/2023 - 10/2009
17	efavirenz (Sustiva)FDA Link 10/2023 - 02/2006
12	Ritonavir (Norvir)FDA Link 01/2020 - 04/2007
11	Antiviral Agents (Antivirals)IBA 01/2023 - 04/2005
10	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 05/2003
9	RacivirIBA 11/2023 - 05/2012
9	NucleosidesIBA 01/2022 - 03/2002
8	doravirineIBA 05/2024 - 01/2018
8	Doxycycline (Periostat)FDA LinkGeneric 02/2024 - 03/2012
8	LipidsIBA 12/2023 - 01/2007
7	Ribavirin (Virazole)FDA LinkGeneric 01/2017 - 07/2010
6	VaccinesIBA 03/2024 - 03/2012
6	AntibodiesIBA 11/2023 - 05/2003
6	Lamivudine (Epivir)FDA Link 01/2022 - 06/2014
6	Protease Inhibitors (Protease Inhibitor)IBA 01/2022 - 06/2005
6	Rilpivirine (TMC-278)IBA 09/2020 - 07/2011
6	tenofovir alafenamideIBA 01/2020 - 01/2017
6	Atazanavir Sulfate (Reyataz)FDA Link 03/2014 - 08/2008
5	elvitegravirIBA 01/2023 - 04/2013
5	TabletsIBA 12/2022 - 03/2014
5	Darunavir (Prezista)FDA Link 01/2020 - 04/2007
4	Anti-Bacterial Agents (Antibiotics)IBA 03/2024 - 05/2003
4	CreatinineIBA 12/2023 - 04/2003
4	CobicistatIBA 01/2023 - 04/2013
4	Reverse Transcriptase InhibitorsIBA 01/2022 - 01/2007
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2009
4	AntigensIBA 01/2021 - 01/2015
4	abacavir (Ziagen)FDA Link 01/2018 - 02/2008
4	InterferonsIBA 03/2015 - 07/2010
4	Enfuvirtide (Fuzeon)FDA Link 09/2011 - 10/2009
3	islatravirIBA 05/2024 - 01/2021
3	dolutegravirIBA 01/2022 - 04/2015
3	Integrase InhibitorsIBA 02/2020 - 03/2011
3	daclatasvirIBA 01/2017 - 09/2015
3	Lopinavir FDA Link 01/2015 - 08/2008
3	HLA-B Antigens (HLA-B)IBA 09/2013 - 02/2008
3	Glucose (Dextrose)FDA LinkGeneric 01/2011 - 12/2003
2	Azithromycin (Zithromax)FDA LinkGeneric 01/2023 - 10/2021
2	Illicit Drugs (Recreational Drugs)IBA 01/2023 - 01/2022
2	IntegrasesIBA 01/2022 - 03/2011
2	Rifampin (Rifampicin)FDA LinkGeneric 01/2022 - 01/2021
2	fumagillinIBA 01/2021 - 06/2002
2	EnzymesIBA 01/2021 - 01/2019
2	cobicistat mixture with darunavirIBA 01/2019 - 01/2018
2	bictegravirIBA 01/2018 - 01/2018
2	Immunoglobulin G (IgG)IBA 03/2017 - 04/2012
2	SofosbuvirIBA 01/2017 - 03/2015
2	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 03/2016 - 01/2016
2	N- (8- aminohexyl)- 5- iodonaphthalene- 1- sulfonamide (W8)IBA 03/2016 - 01/2016
2	BilirubinIBA 01/2014 - 08/2008

Therapy/Procedure

50	Therapeutics 10/2023 - 03/2002
14	Highly Active Antiretroviral Therapy (HAART) 03/2017 - 11/2005
8	Art Therapy 03/2024 - 01/2012
7	Condoms (Condom) 03/2024 - 12/2015
3	Duration of Therapy 01/2022 - 07/2010
3	Hematopoietic Stem Cell Transplantation 01/2022 - 09/2007
2	Stem Cell Transplantation 04/2022 - 09/2007
2	Aftercare (After-Treatment) 01/2022 - 01/2017
2	Transplantation 04/2021 - 04/2014
2	Injections 09/2020 - 04/2005
2	Drug Therapy (Chemotherapy) 04/2015 - 12/2003
2	Blood Transfusion (Blood Transfusions) 12/2014 - 11/2008